In order to evaluate FGF 21 as an endometrial cancer marker, we compared its diagnostic value with CA 125 and HE4, previously described markers, whose role in the diagnostic and prognostic process is well documented [22,23,24,25,26,27,28]. The gene discussed is WFDC2; the disease is endometrial cancer.